All Updates

All Updates

icon
Filter
Partnerships
Oxford Nanopore Technologies partners with UK Biobank for study targeting causes of major diseases
Precision Medicine
Nov 27, 2024
This week:
Partnerships
AML3D partners with Tennessee Valley Authority to provide advanced additive manufacturing system
Additive Manufacturing
Today
Industry news
Bragar Eagel & Squire files class action lawsuit against Symbotic
Logistics Tech
Today
Product updates
Silverfort launches Privileged Access Security for identity protection
Identity & Access Management
Yesterday
Product updates
RSA launches passwordless authentication app and security key
Identity & Access Management
Yesterday
Partnerships
SonicWall partners with CrowdStrike to offer managed detection and response for SMBs
Next-gen Cybersecurity
Yesterday
Product updates
Industry news
Axiom Space launches Ax-4 mission with international astronauts
Space Travel and Exploration Tech
Yesterday
Partnerships
SpaceX partners with US DoD to provide Starshield satellite access to Ukraine
Next-gen Satellites
Yesterday
Funding
SES Space & Defense secures USD 117 million DoD contract for European satellite services
Next-gen Satellites
Yesterday
Funding
Friend raises USD 5.4 million in seed funding to develop AI companion platform
Generative AI Applications
Yesterday
Product updates
Remote launches Recruit AI for global talent matching
Remote Work Infrastructure
Yesterday
Precision Medicine

Precision Medicine

Nov 27, 2024

Oxford Nanopore Technologies partners with UK Biobank for study targeting causes of major diseases

Partnerships

  • Oxford Nanopore Technologies has partnered with biomedical database and research resource UK Biobank for an epigenetic study targeting the causes of diseases such as cancer and dementia.

  • The collaboration aims to analyze the epigenome of 50,000 participant samples. By capturing comprehensive methylation data, the aim is to gain a comprehensive understanding of disease causes and progression, potentially allowing the development of personalized treatments for various diseases,, including cancer and dementia.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.